Stock listing
NASDAQ:KNSY Kensey Nash Corp Stock
Follow Kensey Nash Corp into a list and get an email when it puts out news.
Last close · NASDAQ:KNSY
$38.46 USD
Close on Jun 22, 2012 · No longer trades
- Lowest – highest close
- $5.75 – $38.59 USDSince Dec 31, 1997 · lowest Oct 13, 1998 · highest May 24, 2012
Delisted NASDAQ:KNSY no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:KNSY
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Celano Other companies: Larimar Therapeutics, Inc. (Chief Financial Officer · Since at least May 28, 2020); Recro Pharma Inc (Chief Operating Officer · Jul 5, 2016 – Jan 18, 2019 · Past); OraSure Technologies, Inc. (Director · Oct 4, 2006 – Aug 12, 2022 · Past) | Chief Financial Officer · Mar 10, 2009 – Jun 22, 2012 · Past |
| Douglas G Evans Other companies: TELA Bio, Inc. (Director · Since at least Apr 20, 2020) | COO, Director · Apr 9, 2007 – Jun 22, 2012 · Past |
| Jeffrey M Solomon Other companies: Cowen Group Inc (CHAIR AND CEO, Director · Nov 2, 2009 – Mar 1, 2023 · Past) | Director · Oct 20, 2008 – Feb 3, 2009 · Past |
| Kim D Rosenberg | Director · Oct 5, 2007 – Oct 5, 2007 · Past |
| M Kevin Carouge | VP Biomaterials Market Develop · Jul 22, 2008 – Sep 22, 2008 · Past |
| Todd M DeWitt | VP of Biomaterials · Jul 22, 2008 – Jun 22, 2012 · Past |
Log in to ask 6ix AI your own questions about Kensey Nash Corp.